Overview Financials News + Filings Key Docs Charts Ownership Insiders |
CLS Holdings USA, Inc. (CLSH)
|
Add to portfolio |
|
|
Price: |
$0.09
| | Metrics |
OS: |
72.5
|
M
| |
|
|
Market cap: |
$6.53
|
M
| |
|
|
Net debt:
|
$10.6
|
M
| |
9.4
|
x Debt/EBITDA
|
EV:
|
$17.1
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
$1.1
|
M
| |
15.2
|
x EV/EBITDA
|
EBIT
|
$311.4
|
k
| |
54.9
|
x EV/EBIT
|
EPS |
($0.09)
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | May-31-23 | May-31-22 | May-31-21 | May-31-20 | May-31-19 | May-31-18 | May-31-17 | May-31-16 |
Revenues | 23.1 | 22.7 | 19.3 | 11.9 | 8.5 | 0.0 | 0.0 | 0.0 |
Revenue growth | 2.1% | 17.5% | 61.9% | 40.9% | | | | |
Cost of goods sold | 13.3 | 12.2 | 9.6 | 6.0 | 4.8 | 0.0 | 0.0 | 0.0 |
Gross profit | 9.8 | 10.5 | 9.6 | 6.0 | 3.6 | 0.0 | 0.0 | 0.0 |
Gross margin | 42.4% | 46.3% | 50.0% | 50.0% | 42.8% | | | |
Selling, general and administrative | | | | | | | | |
General and administrative | 11.1 | 11.4 | 10.8 | 8.8 | 26.5 | 3.1 | 1.5 | 2.3 |
EBITA | -3.0 | -0.9 | -1.1 | -2.7 | -22.4 | -3.1 | -1.6 | -2.3 |
EBITA margin | -12.8% | -3.9% | -5.5% | -22.7% | -264.9% | | | |
Amortization of intangibles | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | | |
EBIT | -3.1 | -1.0 | -1.2 | -2.8 | -22.5 | -3.1 | -1.6 | -2.3 |
EBIT margin | -13.3% | -4.4% | -6.1% | -23.7% | -266.3% | | | |
Pre-tax income | -12.6 | -0.4 | -13.4 | -30.7 | -27.6 | -9.6 | -4.9 | -2.6 |
Income taxes | 2.2 | 2.0 | 2.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | | | | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -13.8 | -2.3 | -15.9 | -30.7 | -27.6 | -9.6 | -4.9 | -2.6 |
Net margin | -59.7% | -10.3% | -82.4% | -257.2% | -326.5% | | | |
|
Diluted EPS | ($0.23) | ($0.07) | ($0.13) | ($0.24) | ($0.27) | ($0.24) | ($0.23) | ($0.13) |
Shares outstanding (diluted) | 60.7 | 32.0 | 126.7 | 126.4 | 102.9 | 39.2 | 20.8 | 20.1 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|